• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

尽管在前列腺病变和 PI-RADS 分级方面,非裔美国男性的前列腺癌检出率相似,但他们的前列腺癌检出风险仍增加。

African American Men have Increased Risk of Prostate Cancer Detection Despite Similar Rates of Anterior Prostatic Lesions and PI-RADS Grade on Multiparametric Magnetic Resonance Imaging.

机构信息

Department of Urology, Loyola University Medical Center, Maywood, Illinois.

Department of Urology, Loyola University Medical Center, Maywood, Illinois.

出版信息

Urology. 2022 May;163:132-137. doi: 10.1016/j.urology.2021.07.005. Epub 2021 Jul 21.

DOI:10.1016/j.urology.2021.07.005
PMID:34302832
Abstract

OBJECTIVE

To determine whether the frequency of anterior prostate lesions (APL) on multiparametric magnetic resonance imaging (mpMRI) prior to biopsy differed between African American (AA) and non-AA men and evaluate implications of race and tumor location for prostate cancer (PCa) detection.

METHODS

Patients from the Prospective Loyola University mpMRI (PLUM) Prostate Biopsy Cohort (January 2015-December 2020) without prior diagnosis of PCa were evaluated for APLs by race. Multivariable logistic regression models evaluated predictors of APLs and associations of APLs and race with detection of any PCa (grade group 1+) and clinically significant PCa (csPCa; grade group 2+). Additional stratified and propensity score matched analyses were conducted.

RESULTS

Of 1,239 men included, 190 (15.3%) were AA and 302 (24.4%) had at least one APL with no differences by race on multivariable analysis. While men with APLs were twice as likely to harbor PCa or csPCa, the unadjusted proportion of targeted biopsy-confirmed APL PCa (12.6% vs 12.0%) or csPCa (8.4% vs 8.9%) were similar for AA and non-AA men. AA men had higher risk of prostate cancer on targeted cores (OR 1.66 (95%CI 1.06 - 2.61), P = 0.026) which was independent of lesion location or PI-RADS.

CONCLUSION

AA men were found to have similar rates of APLs on mpMRI to non-AA men indicating access to mpMRI may mitigate some of the historical racial disparity based on lesion location. AA men have increased risk of PCa detection compared to non-AA men independent of anterior location or lesion grade on mpMRI reinforcing the importance of identifying genetic, biologic, and socioeconomic drivers.

摘要

目的

确定接受活检前多参数磁共振成像(mpMRI)的非洲裔美国(AA)男性和非 AA 男性的前前列腺病变(APL)频率是否存在差异,并评估种族和肿瘤位置对前列腺癌(PCa)检测的影响。

方法

回顾性分析 2015 年 1 月至 2020 年 12 月 ProspectiveLoyolaUniversitympMRI(PLUM)前列腺活检队列中未诊断为 PCa 的患者的 APL 情况。多变量逻辑回归模型评估了 APL 预测因素以及 APL 和种族与任何 PCa(分级组 1+)和临床显著 PCa(csPCa;分级组 2+)检测之间的相关性。此外还进行了分层和倾向评分匹配分析。

结果

在纳入的 1239 名男性中,190 名(15.3%)为 AA 男性,302 名(24.4%)至少有一个 APL,但在多变量分析中,种族间无差异。虽然有 APL 的男性患 PCa 或 csPCa 的可能性是两倍,但 AA 男性和非 AA 男性靶向活检证实的 APLPCa(12.6% vs 12.0%)或 csPCa(8.4% vs 8.9%)的比例相似。AA 男性在靶向核心中患前列腺癌的风险更高(OR1.66(95%CI1.06-2.61),P=0.026),这独立于病变位置或 PI-RADS。

结论

AA 男性在 mpMRI 上的 APL 发生率与非 AA 男性相似,这表明获得 mpMRI 可能会减轻部分基于病变位置的历史种族差异。与非 AA 男性相比,AA 男性在 mpMRI 上的前位或病变分级无关的情况下,检测到 PCa 的风险增加,这进一步证实了识别遗传、生物学和社会经济驱动因素的重要性。

相似文献

1
African American Men have Increased Risk of Prostate Cancer Detection Despite Similar Rates of Anterior Prostatic Lesions and PI-RADS Grade on Multiparametric Magnetic Resonance Imaging.尽管在前列腺病变和 PI-RADS 分级方面,非裔美国男性的前列腺癌检出率相似,但他们的前列腺癌检出风险仍增加。
Urology. 2022 May;163:132-137. doi: 10.1016/j.urology.2021.07.005. Epub 2021 Jul 21.
2
The significance of anterior prostate lesions on multiparametric magnetic resonance imaging in African-American men.非洲裔美国男性前列腺前部病变在多参数磁共振成像中的意义。
Urol Oncol. 2016 Jun;34(6):254.e15-21. doi: 10.1016/j.urolonc.2015.12.018. Epub 2016 Feb 20.
3
A prostate biopsy risk calculator based on MRI: development and comparison of the Prospective Loyola University multiparametric MRI (PLUM) and Prostate Biopsy Collaborative Group (PBCG) risk calculators.基于 MRI 的前列腺活检风险计算器:前瞻性洛约拉大学多参数 MRI(PLUM)和前列腺活检协作组(PBCG)风险计算器的开发和比较。
BJU Int. 2023 Feb;131(2):227-235. doi: 10.1111/bju.15835. Epub 2022 Jul 11.
4
Association Between Prostate Imaging Reporting and Data System (PI-RADS) Score for the Index Lesion and Multifocal, Clinically Significant Prostate Cancer.前列腺影像报告和数据系统(PI-RADS)评分与指数病变和多灶性、临床显著前列腺癌的相关性。
Eur Urol Oncol. 2018 May;1(1):29-36. doi: 10.1016/j.euo.2018.01.002. Epub 2018 May 15.
5
Risk of prostate cancer for men with prior negative biopsies undergoing magnetic resonance imaging compared with biopsy-naive men: A prospective evaluation of the PLUM cohort.对于接受磁共振成像检查的先前活检阴性的男性与活检初筛的男性相比,前列腺癌风险:PLUM 队列的前瞻性评估。
Cancer. 2022 Jan 1;128(1):75-84. doi: 10.1002/cncr.33875. Epub 2021 Aug 24.
6
Prostate cancer detection rate in men undergoing transperineal template-guided saturation and targeted prostate biopsy.经会阴模板引导式饱和与靶向前列腺活检的男性前列腺癌检出率。
Prostate. 2022 Feb;82(3):388-396. doi: 10.1002/pros.24286. Epub 2021 Dec 16.
7
Positive Predictive Value of Prostate Imaging Reporting and Data System Version 2 for the Detection of Clinically Significant Prostate Cancer: A Systematic Review and Meta-analysis.前列腺影像报告和数据系统第 2 版检测临床显著前列腺癌的阳性预测值:系统评价和荟萃分析。
Eur Urol Oncol. 2021 Oct;4(5):697-713. doi: 10.1016/j.euo.2020.12.004. Epub 2020 Dec 25.
8
Multifocality of Prostate Cancer and Candidacy for Focal Therapy Based on Magnetic Resonance Imaging.前列腺癌的多灶性与基于磁共振成像的局灶性治疗适应证。
Urology. 2022 Nov;169:141-149. doi: 10.1016/j.urology.2022.07.030. Epub 2022 Jul 29.
9
Systematic versus Targeted Magnetic Resonance Imaging/Ultrasound Fusion Prostate Biopsy among Men with Visible Lesions.有可见病灶的男性中,系统与靶向磁共振成像/超声融合前列腺活检的比较。
J Urol. 2022 Jan;207(1):108-117. doi: 10.1097/JU.0000000000002120. Epub 2021 Aug 24.
10
Does previous prostate surgery affect multiparametric magnetic resonance imaging accuracy in detecting clinically significant prostate cancer? Results from a single institution series.既往前列腺手术是否会影响多参数磁共振成像检测临床显著前列腺癌的准确性?来自单机构系列的结果。
Prostate. 2022 Sep;82(12):1170-1175. doi: 10.1002/pros.24368. Epub 2022 May 10.

引用本文的文献

1
Evaluating PI-RADS lesions and clinically significant prostate cancer in Black and Asian men: a PREVENT randomized clinical trial secondary analysis.评估黑人和亚洲男性的PI-RADS病变及临床显著前列腺癌:一项PREVENT随机临床试验的二次分析
Res Sq. 2025 Jul 4:rs.3.rs-6905600. doi: 10.21203/rs.3.rs-6905600/v1.
2
Comparison of Magnetic Resonance Imaging-Based Risk Calculators to Predict Prostate Cancer Risk.基于磁共振成像的风险计算器预测前列腺癌风险的比较。
JAMA Netw Open. 2024 Mar 4;7(3):e241516. doi: 10.1001/jamanetworkopen.2024.1516.
3
Concerns regarding prostate cancer screening guidelines in minority populations.
对少数族裔人群前列腺癌筛查指南的担忧。
Prostate Cancer Prostatic Dis. 2024 Dec;27(4):591-593. doi: 10.1038/s41391-023-00765-0. Epub 2023 Dec 19.
4
African American Prostate Cancer Displays Quantitatively Distinct Vitamin D Receptor Cistrome-transcriptome Relationships Regulated by BAZ1A.非裔美国人前列腺癌表现出维生素 D 受体染色质组-转录组关系的定量差异,受 BAZ1A 调控。
Cancer Res Commun. 2023 Apr 18;3(4):621-639. doi: 10.1158/2767-9764.CRC-22-0389. eCollection 2023 Apr.
5
Vitamin D and Systems Biology.维生素 D 与系统生物学。
Nutrients. 2022 Dec 7;14(24):5197. doi: 10.3390/nu14245197.
6
Construction and Comparison of Different Models in Detecting Prostate Cancer and Clinically Significant Prostate Cancer.检测前列腺癌及临床显著性前列腺癌不同模型的构建与比较
Front Oncol. 2022 Jul 12;12:911725. doi: 10.3389/fonc.2022.911725. eCollection 2022.
7
A narrative review of biparametric MRI (bpMRI) implementation on screening, detection, and the overall accuracy for prostate cancer.关于双参数磁共振成像(bpMRI)在前列腺癌筛查、检测及总体准确性方面应用的叙述性综述。
Ther Adv Urol. 2022 May 4;14:17562872221096377. doi: 10.1177/17562872221096377. eCollection 2022 Jan-Dec.
8
Considering Predictive Factors in the Diagnosis of Clinically Significant Prostate Cancer in Patients with PI-RADS 3 Lesions.考虑PI-RADS 3类病变患者临床显著性前列腺癌诊断中的预测因素。
Life (Basel). 2021 Dec 19;11(12):1432. doi: 10.3390/life11121432.